New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease

Figure 8

63M presented with NSTEMI. Coronary angiography demonstrated diffuse triple vessel disease (95% mid-LAD stenosis, 95% OM2 stenosis, 90% proximal LCx stenosis, 90% distal LCx stenosis, 95% OM1 stenosis, 95% ramus intermedius stenosis, 50–60% middistal RCA stenosis, and 60% right PDA stenosis). A ¹³NH₃-¹⁸FDG PET viability study demonstrated approximately 29% of the left ventricle was scar with hibernating myocardium of 6.6%.